Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Bressel

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy PlanningBelinda A Campbell, Jason Callahan, Mathias Bressel, et al.
Journal of Medical Imaging and Radiation Oncology|October 15, 2013
Patterns of retreatment with radiotherapy in a large academic centreRichard Khor, Mathias Bressel, Keen Hun Tai, et al.
Ocular Oncology and Pathology|June 17, 2024
Is It Possible to Preserve Vision without Compromising Metastases-Free Survival by Use of Fully Fractionated Stereotactic Radiotherapy for Posterior Choroidal Melanoma?Claire E Phillips, Arkan Youssef, Mathias Bressel, et al.
Practical Radiation Oncology|October 14, 2019
Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell CarcinomaChristopher P Daniels, Mathias Bressel, June Corry, et al.
British Journal of Haematology|April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
BMC Cancer|March 24, 2021
Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)Reem Alomran, Michelle White, Melissa Bruce, et al.
Radiation Oncology (London, England)|July 25, 2012
A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancerFarshad Foroudi, Lesley Wilson, Mathias Bressel, et al.
BMC Cancer|January 7, 2023
Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer CentreAnnie J Wang, Brendan McCann, William C L Soon, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary AnalysisLachlan McDowell, Mathias Bressel, Madeleine T King, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2023
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II)Nicholas W Bucknell, Nicholas Hardcastle, Mathias Bressel, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy PlanningBelinda A Campbell, Jason Callahan, Mathias Bressel, et al.
Journal of Medical Imaging and Radiation Oncology|October 15, 2013
Patterns of retreatment with radiotherapy in a large academic centreRichard Khor, Mathias Bressel, Keen Hun Tai, et al.
Ocular Oncology and Pathology|June 17, 2024
Is It Possible to Preserve Vision without Compromising Metastases-Free Survival by Use of Fully Fractionated Stereotactic Radiotherapy for Posterior Choroidal Melanoma?Claire E Phillips, Arkan Youssef, Mathias Bressel, et al.
Practical Radiation Oncology|October 14, 2019
Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell CarcinomaChristopher P Daniels, Mathias Bressel, June Corry, et al.
British Journal of Haematology|April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
BMC Cancer|March 24, 2021
Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)Reem Alomran, Michelle White, Melissa Bruce, et al.
Radiation Oncology (London, England)|July 25, 2012
A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancerFarshad Foroudi, Lesley Wilson, Mathias Bressel, et al.
BMC Cancer|January 7, 2023
Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer CentreAnnie J Wang, Brendan McCann, William C L Soon, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary AnalysisLachlan McDowell, Mathias Bressel, Madeleine T King, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2023
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II)Nicholas W Bucknell, Nicholas Hardcastle, Mathias Bressel, et al.
Pageof 14